immunotherapy

immunotherapy

Advertisement

Consolidative Thoracic Radiation Therapy (cTRT) Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Patrick DalySmall Cell Lung Cancer | September 21, 2023

Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ...

Immunotherapy Combination Fails to Improve Survival in Patients With NSCLC

Kerri FitzgeraldNon-Small Cell Lung Cancer | September 19, 2023

The phase III ARTIC trial assessing the use of two immunotherapies—durvalumab and tremelimumab—for previously ...

Lung Cancer Patients With Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy

Rob DillardImmunotherapy in NSCLC | November 16, 2020

A new study shows that lung cancer patients with a particular type of human leukocyte antigen (HLA) are more likely to ...

Advertisement

Advertisement

Latest News

Phase 3 IMforte Trial Meets Primary Endpoints of OS and PFS in Extensive-Stage SCLC

May 23, 2025

The Accelerated Approval of Telisotuzumab Vedotin for NSCLC: Dr. Singhi Shares What Clinicians Should Know

May 23, 2025

Operating in Oligometastatic Disease: Dr. Antonoff Shares Patient Selection Considerations

May 21, 2025

Lung Cancer Screening: Study Explores Impact of Eligibility Differences by Smoking History

May 20, 2025

Breath Test for Lung Cancer Screening Under Evaluation in Pilot Study

May 19, 2025

Study Highlights Relationship Between Lipid Metabolism, NK Cells in the NSCLC Tumor Microenvironment

May 16, 2025